What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
His primary areas of study are Immunology, Cancer research, Immune system, Tumor microenvironment and IL-2 receptor.
His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Tumor progression.
His studies deal with areas such as Carcinogenesis, Cancer stem cell, T cell, Cancer epigenetics and Histone as well as Cancer research.
The concepts of his Immune system study are interwoven with issues in Cancer, Downregulation and upregulation and Cell biology.
His Tumor microenvironment study incorporates themes from Blockade and Angiogenesis.
Weiping Zou has researched IL-2 receptor in several fields, including Chemokine, Interleukin 21 and FOXP3.
His most cited work include:
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. (3925 citations)
- Regulatory T cells, tumour immunity and immunotherapy (1660 citations)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (1630 citations)
What are the main themes of his work throughout his whole career to date?
Weiping Zou focuses on Cancer research, Immunology, Immune system, Immunotherapy and Cancer.
His Cancer research research includes themes of Tumor microenvironment, T cell, CD8, Ovarian cancer and Colorectal cancer.
His study ties his expertise on Myeloid-derived Suppressor Cell together with the subject of Immunology.
His studies in Immune system integrate themes in fields like Cytokine, Antigen and Cell biology.
His work focuses on many connections between Immunotherapy and other disciplines, such as Immunity, that overlap with his field of interest in Apoptosis.
Weiping Zou combines subjects such as Cell and Stem cell with his study of Cancer.
He most often published in these fields:
- Cancer research (53.25%)
- Immunology (39.39%)
- Immune system (36.36%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (53.25%)
- Immunotherapy (25.97%)
- Immune system (36.36%)
In recent papers he was focusing on the following fields of study:
Weiping Zou mainly focuses on Cancer research, Immunotherapy, Immune system, T cell and Chemistry.
His Cancer research research includes elements of Immune checkpoint, Tumor microenvironment, Cancer, CD8 and Cancer immunotherapy.
His study on Metastasis is often connected to Histocompatibility Antigens Class I as part of broader study in Cancer.
His Immunotherapy study combines topics from a wide range of disciplines, such as Dendritic cell, Immunity, SLC7A11, Radiation therapy and Antigen presentation.
By researching both Immune system and Methionine, Weiping Zou produces research that crosses academic boundaries.
The various areas that Weiping Zou examines in his T cell study include Histone methylation, Ovarian cancer, Epigenetics and Interleukin 17.
Between 2018 and 2021, his most popular works were:
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy (246 citations)
- Cancer nanomedicine for combination cancer immunotherapy (184 citations)
- Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11 (88 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Weiping Zou mainly investigates Cancer research, Immunotherapy, T cell, Immune system and CD8.
Weiping Zou interconnects Immune checkpoint, Downregulation and upregulation, Radiation therapy and Cancer immunotherapy in the investigation of issues within Cancer research.
His study in Immunotherapy is interdisciplinary in nature, drawing from both Clinical trial and SLC7A11.
His work investigates the relationship between T cell and topics such as Epigenetics that intersect with problems in Chromatin.
His Immune system research integrates issues from Phenotype, Cancer, Ovarian cancer and Adenosine.
His Cancer research is multidisciplinary, incorporating elements of Peripheral tolerance and Immune tolerance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
